Gene · 7185
Papers2,530
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,530
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Receptor Interacting Protein (RIP) kinases in cancer. | Genes Dis | 2022 | 36157481 | PubTator, text mining | PubMed |
| B-Cell Translocation Gene 2 Upregulation Is Associated with Favorable Prognosis in Lung Adenocarcinoma and Prolonged Patient Survival. | J Oncol | 2022 | 36157236 | PubTator, text mining | PubMed |
| Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas. | Int J Mol Sci | 2022 | 36142875 | PubTator, text mining | PubMed |
| Whole-Transcriptome Sequencing Analyses of Nuclear Antixoxidant-1 in Endothelial Cells: Role in Inflammation and Atherosclerosis. | Cells | 2022 | 36139494 | PubTator, text mining | PubMed |
| Co-Stimulatory Receptor Signaling in CAR-T Cells. | Biomolecules | 2022 | 36139142 | PubTator, text mining | PubMed |
| The Th1/Tfh-like biased responses elicited by the rASP-1 innate adjuvant are dependent on TRIF and Type I IFN receptor pathways. | Front Immunol | 2022 | 36119026 | PubTator, text mining | PubMed |
| Clonal hematopoiesis of indeterminate potential, DNA methylation, and risk for coronary artery disease. | Nat Commun | 2022 | 36097025 | PubTator, text mining | PubMed |
| Integrated co-expression network analysis uncovers novel tissue-specific genes in major depressive disorder and bipolar disorder. | Front Psychiatry | 2022 | 36081461 | PubTator, text mining | PubMed |
| Differential Epigenetic Status and Responses to Stressors between Retinal Cybrids Cells with African versus European Mitochondrial DNA: Insights into Disease Susceptibilities. | Cells | 2022 | 36078063 | PubTator, text mining | PubMed |
| TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway. | Int J Mol Sci | 2022 | 36077559 | PubTator, text mining | PubMed |
| Intracellular Pathways and Mechanisms of Colored Secondary Metabolites in Cancer Therapy. | Int J Mol Sci | 2022 | 36077338 | PubTator, text mining | PubMed |
| Construction of the coexpression network involved in the pathogenesis of thyroid eye disease via bioinformatics analysis. | Hum Genomics | 2022 | 36076300 | PubTator, text mining | PubMed |
| Methionine metabolism controls the B cell EBV epigenome and viral latency. | Cell Metab | 2022 | 36070681 | PubTator, text mining | PubMed |
| PSEN1 is associated with colon cancer development via potential influences on PD-L1 nuclear translocation and tumor-immune interactions. | Front Immunol | 2022 | 36059511 | PubTator, text mining | PubMed |
| Assessing the suitability of long non-coding RNAs as therapeutic targets and biomarkers in SARS-CoV-2 infection. | Front Mol Biosci | 2022 | 36052163 | PubTator, text mining | PubMed |
| Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future. | Front Oncol | 2022 | 36046036 | PubTator, text mining | PubMed |
| Study of The Correlation between miR-106a, miR-125b, and miR-330 on Multiple Sclerosis Patients by Targeting TNFSF4 and SP1 in NF-кb/TNF-α Pathway: A Case-Control Study. | Cell J | 2022 | 36043408 | PubTator, text mining | PubMed |
| Emerging trends and hot spots in autoimmune thyroiditis research from 2000 to 2022: A bibliometric analysis. | Front Immunol | 2022 | 36032148 | PubTator, text mining | PubMed |
| Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study. | Lancet Respir Med | 2022 | 36029799 | PubTator, text mining | PubMed |
| Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis. | J Pers Med | 2022 | 36013214 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7185/papers?page=17